A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include truthful and non-misleading pricing information.
About This Bill
Committee
Latest Action · May 13, 2019
Read twice and referred to the Committee on Finance. (text: CR S2791)
Drug-price Transparency in Communications (DTC) Act
This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.